News & Updates

Antigliadin IgG spots IBS patients who benefit from gluten-free diet
Antigliadin IgG spots IBS patients who benefit from gluten-free diet
02 Nov 2021

Some patients with irritable bowel syndrome (IBS) may achieve symptom reduction, particularly diarrhoea, on a gluten-free diet, and who these patients are may be identified by using the antigliadin immunoglobulin G (IgG) as a biomarker, according to a study.

Antigliadin IgG spots IBS patients who benefit from gluten-free diet
02 Nov 2021
Sustained benefit with anti-TNFα less likely to lead to subsequent loss of response in IBD
Sustained benefit with anti-TNFα less likely to lead to subsequent loss of response in IBD
01 Nov 2021

Inflammatory bowel disease (IBD) patients receiving treatment with antitumour necrosis factor alpha (anti-TNFα) for more than 2 years represent a distinct group who obtain prolonged clinical benefit and tolerate maintenance treatment, according to a study.

Sustained benefit with anti-TNFα less likely to lead to subsequent loss of response in IBD
01 Nov 2021
Patients presenting with advanced-stage pancreatic cancer reveal cracks in imaging-based surveillance
Patients presenting with advanced-stage pancreatic cancer reveal cracks in imaging-based surveillance
31 Oct 2021

High-risk individuals who develop neoplastic progression to pancreatic cancer or high-grade dysplasia can present at an advanced stage despite showing no lesions during prior imaging surveillance evaluations, a new study has found.

Patients presenting with advanced-stage pancreatic cancer reveal cracks in imaging-based surveillance
31 Oct 2021